Scientist Immunopeptidomics & Proteomics*
at Immatics Biotechnologies GmbH
72076 Tübingen, Baden-Württemberg, Germany -
Start Date | Expiry Date | Salary | Posted On | Experience | Skills | Telecommute | Sponsor Visa |
---|---|---|---|---|---|---|---|
Immediate | 12 Jul, 2024 | Not Specified | 13 Apr, 2024 | N/A | Good communication skills | No | No |
Required Visa Status:
Citizen | GC |
US Citizen | Student Visa |
H1B | CPT |
OPT | H4 Spouse of H1B |
GC Green Card |
Employment Type:
Full Time | Part Time |
Permanent | Independent - 1099 |
Contract – W2 | C2H Independent |
C2H W2 | Contract – Corp 2 Corp |
Contract to Hire – Corp 2 Corp |
Description:
OVERVIEW
We are currently seeking a Scientist Immunopeptidomics & Proteomics* to strengthen our team in the research and development of innovative immunotherapeutic products. You will work in Tuebingen (Germany) in an interdisciplinary environment with colleagues from all research and preclinical/ clinical development departments.
ABOUT US
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. Operating from Tuebingen, Munich and Houston, we are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer. For more detailed information, visit www.immatics.com.
Responsibilities:
- Characterization of HLA presented peptides using Immatics’ proprietary absolute quantitation technology (AbsQuant®) to identify and validate the best targets for clinical development
- Development and validation of new proteomics & peptidomics methodologies for target characterization using a diverse set of protein chemistry and mass spectrometry techniques
- Coordination and project management of target characterization activities involving stakeholders from different departments and disciplines
- Contribution to the elucidation of the biological mechanisms of novel cryptic targets using various Omics datasets integrated in Immatics’ XPRESIDENT® target discovery and validation platfor
REQUIREMENT SUMMARY
Min:N/AMax:5.0 year(s)
Pharmaceuticals
Pharma / Biotech / Healthcare / Medical / R&D
Clinical Pharmacy
Graduate
Proficient
1
72076 Tübingen, Germany